DYRK1A and familial pancreatic carcinoma: Moreover, taking advantage of the combination of CRISPR-Cas9 and 3D cell spheroid culture, Lan et al. detected DYRK1A as a sensitive target for radiotherapy in pancreatic cancer cells [63].